CLYM•benzinga•
Climb Bio Entered Technology Transfer And Exclusive License Agreement With Beijing Mabworks Biotech Co.; Climb Obligated To Pay Mabworks $9M Upfront And Up To $30M On Milestones, With Total Up To $832M Upon Achievement Of Certain Milestones For All Licens
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga